Product Code: HIT 2005
The global Healthcare IT market is projected to reach 834.35 billion by 2029 from 420.23 billion in 2024, at a CAGR of 14.7% from 2024 to 2029. The widespread adoption of technology advancement solutions is accelerating the growth of the healthcare IT market. According to the Healthcare article published in August 2024, AI-powered clinical decision support systems assist oncologists by making evidence-based therapy recommendations. It was found that AI helped in improving the dignaostics accuracy by 10-15%. Moreover, increased adoptions of EHRs improve data accessibility and drive the demand for advanced healthcare IT solutions.
Scope of the Report |
Years Considered for the Study | 2022-2029 |
Base Year | 2023 |
Forecast Period | 2024-2029 |
Units Considered | Million/Billion (USD) |
Segments | By Solution & Service, Component, and End-user |
Regions covered | North America, Europe, Asia Pacific, Latin America, and Middle East Africa. |
"The telehealth solutions segment is projected to be the largest segment in the clinical healthcare IT market"
Based on the type of clinical HCIT solutions, the telehealth solutions segment is projected to be the largest segment during the forecast period. The COVID-19 pandemic has been a catalyst for significant changes in many sectors, particularly in the healthcare industry. One of the most notable transformations has been the rapid adoption and scaling up of telehealth solutions. This is majorly attributed to the government initiatives for eHealth across the globe. For instance, the WHO Global Strategy on Digital Health 2020-2025, the Slaintecare Action Plan, the HSE Corporate Plan, and Healthy Ireland government initiatives are promoting the development of telehealth solutions. Thus, there is an increasing need to improve the quality of care, growing consolidation among healthcare providers, and the rising adoption of digital and connected healthcare technologies.
"Healthcare Providers was the largest segment by the end user of healthcare IT market in 2023"
Healthcare providers segment is projected to grow at the highest growth rate in the healthcare IT market in 2023. Providers face high demand for digitized, personalized service with staffing challenges. At the same time, health systems strive to advance patient acquisition, proactive care engagement and commitments to their communities. Achieving long-term visions for financially sustainable value-based care and population health management requires healthcare information technology solutions that can improve the patient and employee experience while allowing providers to focus on what they do best - care. Thus, there is a rising demand for healthcare IT solutions to improve patient care while increasing operational efficiency.
"APAC to witness the highest growth rate during the forecast period."
In this report, the healthcare IT market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The healthcare IT market in APAC is projected to register the highest CAGR rate during the forecast period. The growth in the APAC market is mainly driven by factors such as the improving healthcare infrastructure, adoption of technology solutions and government initiatives for the adoption of HCIT solutions. For instance, the recent initiatives by the National Accreditation Board for Hospitals (NABH) to establish standards and guidelines for Hospital Information Systems (HIS) and Electronic Medical Records (EMR) are significantly driving the demand for healthcare technology solutions in India. Launched in September 2023, these digital health standards have already seen 275 hospitals apply for certification, with 100 achieving it. This regulatory push is not only fostering a robust market for healthcare IT solutions but also positioning India to enhance its healthcare delivery through advanced digital infrastructure.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 45%, Tier 2: 35%, and Tier 3: 20%
- By Designation - C-level: 35%, Director-level: 25%, and Others: 40%
- By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.
Optum, Inc.(US), Oracle (US), and Citiustech Inc (US) are some of the key players in the healthcare IT market.
- The study includes an in-depth competitive analysis of these key players in the healthcare IT market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This research report categorizes the healthcare IT market by solution & service (healthcare provider solutions, healthcare payer solutions, HCIT outsourcing services), by component (services, software, and hardware), by end-user (Payers, Providers, and Life Sciences Industry), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the healthcare IT market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the healthcare IT market. Competitive analysis of upcoming startups in the healthcare IT market ecosystem is covered in this report.
Reasons to buy this report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the healthcare IT market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Government mandates & support for HCIT solutions, rising use of big data, high returns on investments associated with HCIT solutions, need to crucial escalating healthcare costs, growing adoption of 2-prescribing, telehealth, mhealth, and other HCIT solutions) restraints (IT infrastructural constraints in developing countries, high cost of deploying HCIT solutions in small and medium-sized hospitals in emerging countries, resistance from traditional healthcare providers) opportunities (rising use of HCIT solutions in outpatient care facilities, cloud-based EHR solutions, shift towards patient-centric healthcare delivery challenges (security concerns, interoperability issues) influencing the growth of the healthcare IT market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare IT market
- Market Development: Comprehensive information about lucrative markets - the report analyses the healthcare IT market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare IT market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Optum, Inc. (US), Cognizant (US), Koninklijke Philips N.V. (Netherlands), Oracle (US), GE Healthcare (US), Dell Inc. (US), Wipro (India), eClinicalWorks (US), SAS Institute Inc. (US), Inovalon (US); among others in the healthcare IT market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.4 YEARS CONSIDERED
- 1.5 CURRENCY
- 1.6 LIMITATIONS
- 1.7 STAKEHOLDERS
- 1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH APPROACH
- 2.1.1 SECONDARY RESEARCH
- 2.1.2 KEY DATA FROM SECONDARY SOURCES
- 2.1.3 PRIMARY DATA
- 2.1.4 KEY DATA FROM PRIMARY SOURCES
- 2.1.5 INSIGHTS FROM PRIMARY EXPERTS
- 2.2 MARKET SIZE ESTIMATION: HEALTHCARE IT MARKET
- 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
- 2.4 MARKET SHARE ESTIMATION
- 2.5 ASSUMPTIONS
- 2.6 LIMITATIONS
- 2.6.1 METHODOLOGY-RELATED LIMITATIONS
- 2.6.2 SCOPE-RELATED LIMITATIONS
- 2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 HEALTHCARE IT MARKET OVERVIEW
- 4.2 HEALTHCARE IT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 4.3 NORTH AMERICA: HEALTHCARE IT MARKET, BY END USER AND COUNTRY (2023)
- 4.4 HEALTHCARE IT MARKET: REGIONAL MIX
- 4.5 HEALTHCARE IT MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Government mandates & support for HCIT solutions
- 5.2.1.2 Rising use of big data in healthcare
- 5.2.1.3 High returns on investment associated with HCIT solutions
- 5.2.1.4 Growing mhealth, telehealth, and remote patient monitoring markets
- 5.2.2 RESTRAINTS
- 5.2.2.1 Infrastructure constraints in developing countries
- 5.2.2.2 High cost of deployment in small and medium-sized hospitals in emerging economies
- 5.2.2.3 Resistance from traditional healthcare providers
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Rising use of HCIT solutions in outpatient care facilities
- 5.2.3.2 Cloud-based EHR solutions
- 5.2.3.3 Shift toward patient-centric healthcare delivery
- 5.2.4 CHALLENGES
- 5.2.4.1 Rising data breach concerns
- 5.2.4.2 Interoperability issues
- 5.2.4.3 Limited availability of skilled personnel
- 5.3 INDUSTRY TRENDS
- 5.3.1 INTEROPERABILITY AND INTEGRATED CARE MODELS
- 5.3.2 CLOUD-BASED IT SOLUTIONS
- 5.3.3 BIG DATA IN HEALTHCARE
- 5.3.4 CLOUD COMPUTING
- 5.3.5 SMART ON FHIR
- 5.4 TECHNOLOGY ANALYSIS
- 5.4.1 MACHINE LEARNING
- 5.4.2 ARTIFICIAL INTELLIGENCE
- 5.4.3 INTERNET OF THINGS
- 5.4.4 BLOCKCHAIN
- 5.4.5 AUGMENTED REALITY
- 5.5 POTENTIAL HCIT TECHNOLOGIES
- 5.5.1 AI PLATFORMS
- 5.5.2 APP-ENABLED PATIENT PORTALS
- 5.5.3 MEDICAL DEVICE DATA INTEGRATION INTO CARE DELIVERY PROCESSES
- 5.6 AI IN HEALTHCARE MARKET
- 5.7 PRICING ANALYSIS
- 5.7.1 CLINICAL DECISION SUPPORT SYSTEMS: PRICING ANALYSIS
- 5.7.2 HCIT INTEGRATION SOLUTIONS: PRICING ANALYSIS
- 5.7.3 LABORATORY INFORMATION SYSTEMS: PRICING ANALYSIS
- 5.7.4 PATIENT REGISTRY SOFTWARE: PRICING ANALYSIS
- 5.7.5 POPULATION HEALTH MANAGEMENT SOLUTIONS: PRICING ANALYSIS
- 5.7.6 INITIAL FEES
- 5.7.7 ANNUAL MAINTENANCE FEES
- 5.7.8 HEALTHCARE ANALYTICS: PRICING ANALYSIS
- 5.7.9 AVERAGE SELLING PRICE, BY REGION
- 5.8 PORTER'S FIVE FORCES ANALYSIS
- 5.9 REGULATORY ANALYSIS
- 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.9.2 NORTH AMERICA
- 5.9.3 EUROPE
- 5.9.4 ASIA PACIFIC
- 5.9.5 MIDDLE EAST & AFRICA
- 5.9.6 LATIN AMERICA
- 5.9.7 GOVERNMENT REGULATIONS
- 5.9.7.1 North America
- 5.9.7.1.1 US
- 5.9.7.1.2 Canada
- 5.9.7.2 Europe
- 5.9.7.2.1 Germany
- 5.9.7.2.2 France
- 5.9.7.2.3 UK
- 5.9.7.2.4 Spain
- 5.9.7.2.5 Italy
- 5.9.7.3 Asia Pacific
- 5.9.7.3.1 China
- 5.9.7.3.2 Japan
- 5.9.7.3.3 India
- 5.9.7.4 Latin America
- 5.9.7.4.1 Brazil
- 5.9.7.4.2 Mexico
- 5.9.7.5 Middle East & Africa
- 5.10 VALUE CHAIN ANALYSIS
- 5.11 ECOSYSTEM ANALYSIS
- 5.12 PATENT ANALYSIS
- 5.12.1 JURISDICTION AND TOP APPLICANT ANALYSIS
- 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 BUYING CRITERIA
- 5.14 KEY CONFERENCES AND EVENTS (2024-2025)
- 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.16 CASE STUDY ANALYSIS
- 5.16.1 CASE STUDY 1: HEALTHCARE ANALYTICS - DATA AND ANALYTICS PLATFORM DRIVES ANNUAL SAVINGS AND BOOSTS IMPROVEMENT CAPACITY IN HEALTHCARE SYSTEM
- 5.16.2 CASE STUDY 2: VNA & PACS - EFFORTLESS INTEGRATION AND INSTANT DATA ACCESS PROVIDED BY SYNAPPS VNA
- 5.16.3 CASE STUDY 3: HEALTH INFORMATION EXCHANGE - HEALTHINFONET AND ORION HEALTH COLLABORATE FOR RAPID DELIVERY OF HIE SERVICES TO PATIENTS AND HEALTHCARE PROVIDERS
- 5.16.4 CASE STUDY 4: RADIATION DOSE MANAGEMENT - FOCUS ON REDUCING RADIATION DOSE
- 5.17 END USER ANALYSIS
- 5.17.1 UNMET NEEDS
- 5.17.2 END USER EXPECTATIONS
- 5.18 HEALTHCARE IT SOLUTIONS BUSINESS MODEL
- 5.19 HEALTHCARE IT SOLUTIONS INVESTMENT LANDSCAPE
- 5.20 IMPACT OF GEN AI IN HEALTHCARE IT MARKET
- 5.20.1 KEY USE CASES
- 5.20.2 KEY USE CASES OF GEN AI IN HEALTHCARE IT SOLUTIONS
- 5.20.3 USE CASES OF GEN AI IMPLEMENTATION IN HEALTHCARE IT SOLUTIONS
- 5.20.4 REVENUE CYCLE MANAGEMENT MARKET
- 5.20.5 TELEHEALTH AND TELEMEDICINE MARKET
- 5.20.6 HEALTHCARE FRAUD ANALYTICS MARKET
- 5.20.7 USERS READINESS AND IMPACT ASSESSMENT
- 5.20.7.1 User readiness
- 5.20.7.1.1 Payers
- 5.20.7.1.2 Providers
- 5.20.7.2 Impact assessment
- 5.20.7.2.1 User A: Payers
- 5.20.7.2.1.1 Implementation
- 5.20.7.2.1.2 Impact
- 5.20.7.2.2 User B: Providers
- 5.20.7.2.2.1 Implementation
- 5.20.7.2.2.2 Impact
6 HEALTHCARE IT MARKET, BY SOLUTION & SERVICE
- 6.1 INTRODUCTION
- 6.2 HEALTHCARE PROVIDER SOLUTIONS
- 6.2.1 CLINICAL HCIT SOLUTIONS
- 6.2.1.1 Electronic health records
- 6.2.1.1.1 Growing demand for EHRs to drive growth
- 6.2.1.2 Population health management
- 6.2.1.2.1 Aggregation and collation advantages to boost adoption
- 6.2.1.3 Specialty information management
- 6.2.1.3.1 Increasing number of surgical procedures conducted globally to drive market growth
- 6.2.1.3.2 Oncology information systems
- 6.2.1.3.3 Cardiovascular information systems
- 6.2.1.3.4 Other specialty information systems
- 6.2.1.4 PACS & VNA
- 6.2.1.4.1 Growing volume of imaging procedures to drive demand
- 6.2.1.5 Mhealth applications
- 6.2.1.5.1 Growing preference for self-care management to propel penetration
- 6.2.1.6 HCIT integration
- 6.2.1.6.1 Help develop data interfaces quickly
- 6.2.1.7 Telehealth solutions
- 6.2.1.7.1 Rising focus on remote monitoring and care to drive market
- 6.2.1.8 Medical image analysis
- 6.2.1.8.1 North America dominates market
- 6.2.1.9 Laboratory information systems
- 6.2.1.9.1 Need for accurate, efficient, and rapid transfer of lab results across networks to drive market growth
- 6.2.1.10 Practice management systems
- 6.2.1.10.1 Incentives for using practice management systems to support adoption
- 6.2.1.11 Clinical decision support systems
- 6.2.1.11.1 Need to minimize errors and ensure regulatory compliance to boost adoption
- 6.2.1.12 Eprescribing solutions
- 6.2.1.12.1 Integrated ePrescribing solutions to offer significant benefits over standalone systems
- 6.2.1.13 Radiology information systems
- 6.2.1.13.1 Integration of RIS with HIS and PACS to attract stakeholder attention and drive growth
- 6.2.1.14 Computerized physician order entry
- 6.2.1.14.1 Effectiveness in minimizing prescription errors to boost adoption
- 6.2.1.15 Patient registry software
- 6.2.1.15.1 Funding from public and private organizations to support market growth
- 6.2.1.16 Infection surveillance
- 6.2.1.16.1 Potential to minimize financial and human impact of infections to support adoption
- 6.2.1.17 Radiation dose management
- 6.2.1.17.1 Need to optimize radiation administration and management to boost growth
- 6.2.2 NON-CLINICAL HEALTHCARE IT SOLUTIONS
- 6.2.2.1 Healthcare asset management
- 6.2.2.1.1 Helps in cost reduction and care improvement
- 6.2.2.2 Revenue cycle management
- 6.2.2.2.1 Front-end RCM Solutions
- 6.2.2.2.1.1 Rising patient volume and subsequent growth in demand for health insurance to support growth
- 6.2.2.2.2 Mid-RCM solutions
- 6.2.2.2.2.1 Need to improve accuracy, review bills, and prevent fraudulent claims to drive growth
- 6.2.2.2.3 Back-end RCM solutions
- 6.2.2.2.3.1 Focus on ensuring accurate payment and fraud prevention to ensure demand
- 6.2.2.3 Healthcare analytics
- 6.2.2.3.1 Clinical analytics
- 6.2.2.3.2 Financial analytics
- 6.2.2.3.3 Operational and administrative analytics
- 6.2.2.4 Customer relationship management
- 6.2.2.4.1 Need for better customer care services to boost segment
- 6.2.2.5 Pharmacy information systems
- 6.2.2.5.1 Demand for automatic refills and popularity of ePrescribing to drive use
- 6.2.2.6 Healthcare interoperability
- 6.2.2.6.1 Potential to improve operational and clinical efficiencies to support adoption
- 6.2.2.7 Healthcare quality management
- 6.2.2.7.1 Data security concerns and high cost of quality reporting to restrain growth
- 6.2.2.8 Supply chain management
- 6.2.2.8.1 Procurement management
- 6.2.2.8.1.1 Potential to maximize profit and manage purchasing cycles to support adoption
- 6.2.2.8.2 Inventory management
- 6.2.2.8.2.1 Support for maintaining optimum inventory to boost use of inventory management
- 6.2.2.9 Medication management
- 6.2.2.9.1 Electronic medication administration
- 6.2.2.9.1.1 Improved patient safety and reduced incidence of adverse drug effects to drive system usage
- 6.2.2.9.2 Barcode medication administration systems
- 6.2.2.9.2.1 Barcode medication administration systems help in better inventory management
- 6.2.2.9.3 Medication inventory management
- 6.2.2.9.3.1 Decision-making support and ease of use to boost demand
- 6.2.2.9.4 Medication assurance
- 6.2.2.9.4.1 Offer better disease management and improved transitional care
- 6.2.2.10 Workforce management
- 6.2.2.10.1 Help healthcare organizations improve accuracy of employee data
- 6.2.2.11 Healthcare information exchange
- 6.2.2.11.1 Accessibility, data integrity, and security of health-related information to push demand
- 6.2.2.12 Medical document management
- 6.2.2.12.1 Rapid ROI, high security, and increased profitability to drive demand
- 6.3 HEALTHCARE PAYER SOLUTIONS
- 6.3.1 CLAIMS MANAGEMENT
- 6.3.1.1 Efficient processing and ease of management to push demand
- 6.3.2 POPULATION HEALTH MANAGEMENT
- 6.3.2.1 Potential for cost reduction to support adoption
- 6.3.3 PHARMACY AUDIT & ANALYSIS
- 6.3.3.1 Focus on decision-making support to drive adoption
- 6.3.4 CUSTOMER RELATIONSHIP MANAGEMENT
- 6.3.4.1 Focus on better and more effective CRM to boost adoption
- 6.3.5 FRAUD ANALYTICS SOLUTIONS
- 6.3.5.1 Support for improved claims processing, medical policies, and compliance to drive growth
- 6.3.6 PROVIDER NETWORK MANAGEMENT
- 6.3.6.1 Focus on improving communication and case resolution rate to drive adoption
- 6.4 HCIT OUTSOURCING SERVICES
- 6.4.1 IT INFRASTRUCTURE MANAGEMENT
- 6.4.1.1 High capital requirements to lead to high demand
- 6.4.2 PAYER HCIT OUTSOURCING SERVICES
- 6.4.2.1 Claims management
- 6.4.2.1.1 Rapid turnaround time and reduced errors & costs to drive segment
- 6.4.2.2 Provider network management
- 6.4.2.2.1 Need to focus on core functions to drive outsourcing
- 6.4.2.3 Billing & accounts management
- 6.4.2.3.1 Increased cash flow, reduced burden, and low space requirements to drive adoption
- 6.4.2.4 Fraud analytics
- 6.4.2.4.1 Need for better fraud management to ensure demand
- 6.4.2.5 Other payer HCIT outsourcing services
- 6.4.3 PROVIDER HCIT OUTSOURCING SERVICES
- 6.4.3.1 Revenue cycle management
- 6.4.3.1.1 High cost of setting up IT infrastructure for RCM to drive segment
- 6.4.3.2 Medical documents management
- 6.4.3.2.1 Benefits of outsourcing document management to push adoption among providers
- 6.4.3.3 Laboratory information management
- 6.4.3.3.1 Benefits of effective laboratory information management to boost growth
- 6.4.3.4 Other provider HCIT outsourcing services
- 6.4.4 OPERATIONAL HCIT OUTSOURCING SERVICES
- 6.4.4.1 Supply chain management
- 6.4.4.1.1 Rising cost of supply procurement to support demand
- 6.4.4.2 Business process management
- 6.4.4.2.1 Need for automating operational processes to drive adoption
- 6.4.4.3 Other operational HCIT outsourcing services
7 HEALTHCARE IT MARKET, BY COMPONENT
- 7.1 INTRODUCTION
- 7.2 SERVICES
- 7.2.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES
- 7.3 SOFTWARE
- 7.3.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH
- 7.4 HARDWARE
- 7.4.1 NEED FOR FREQUENT HARDWARE UPGRADES TO DRIVE MARKET GROWTH
8 HEALTHCARE IT MARKET, BY END USER
- 8.1 INTRODUCTION
- 8.2 HEALTHCARE PROVIDERS
- 8.2.1 HOSPITALS
- 8.2.1.1 Growing need to improve profitability of healthcare to drive adoption
- 8.2.2 AMBULATORY CARE CENTERS (OUTPATIENT SETTINGS)
- 8.2.2.1 Supportive government norms and incentives to drive market growth
- 8.2.3 HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES
- 8.2.3.1 Growing need for long-term home care to drive market growth
- 8.2.4 DIAGNOSTIC & IMAGING CENTERS
- 8.2.4.1 Growing burden of various chronic diseases to propel market growth
- 8.2.5 PHARMACIES
- 8.2.5.1 Workflow improvements and error reduction to drive adoption
- 8.3 HEALTHCARE PAYERS
- 8.3.1 PRIVATE PAYERS
- 8.3.1.1 Possible increases in operational efficiency to boost demand
- 8.3.2 PUBLIC PAYERS
- 8.3.2.1 Focus on developing outcome-based payment models to drive demand
- 8.4 LIFE SCIENCES INDUSTRY
9 HEALTHCARE IT MARKET, BY REGION
- 9.1 INTRODUCTION
- 9.2 NORTH AMERICA
- 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
- 9.2.2 US
- 9.2.2.1 Vast healthcare infrastructure, reforms, and advancements in digital innovation to make US dominant global market
- 9.2.3 CANADA
- 9.2.3.1 Government investment in health infrastructure and prevalence of digital solutions such as EHRs
- 9.3 EUROPE
- 9.3.1 EUROPE: MACROECONOMIC OUTLOOK
- 9.3.2 GERMANY
- 9.3.2.1 Market expansion through government initiatives, digital upgrades, and record management innovation
- 9.3.3 UK
- 9.3.3.1 Government initiatives involving substantial public engagement and investments in recovery
- 9.3.4 FRANCE
- 9.3.4.1 Robust healthcare system-driving innovation and attracting foreign healthcare investments
- 9.3.5 ITALY
- 9.3.5.1 Need for integrated healthcare solutions and digitization of health records to enhance patient care
- 9.3.6 SPAIN
- 9.3.6.1 High potential for use of IT among GPs; innovations by large technology players
- 9.3.7 REST OF EUROPE
- 9.4 ASIA PACIFIC
- 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
- 9.4.2 JAPAN
- 9.4.2.1 Well-established technological prowess and rapidly evolving mobile healthcare sector
- 9.4.3 CHINA
- 9.4.3.1 Strong government support through initiatives such as Healthy China 2030
- 9.4.4 INDIA
- 9.4.4.1 Rising FDI and government focus through initiatives such as Ayushman Bharat Digital Mission
- 9.4.5 REST OF ASIA PACIFIC
- 9.5 LATIN AMERICA
- 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
- 9.5.2 BRAZIL
- 9.5.2.1 Brazil to dominate Latin American market with two major telehealth initiatives and significant investments
- 9.5.3 MEXICO
- 9.5.3.1 Government strategies and proximity to US with favorable cost differences
- 9.5.4 REST OF LATIN AMERICA
- 9.6 MIDDLE EAST & AFRICA
- 9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
- 9.6.2 GCC COUNTRIES
- 9.6.2.1 Leveraging IT solutions through public-private partnerships and government initiatives to close demand-supply gaps
- 9.6.3 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
- 10.1 OVERVIEW
- 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 10.3 REVENUE ANALYSIS
- 10.4 MARKET SHARE ANALYSIS
- 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 10.5.1 STARS
- 10.5.2 EMERGING LEADERS
- 10.5.3 PERVASIVE PLAYERS
- 10.5.4 PARTICIPANTS
- 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 10.5.5.1 Company footprint
- 10.5.5.2 Solution and service footprint
- 10.5.5.3 Component footprint
- 10.5.5.4 End user footprint
- 10.5.5.5 Regional footprint
- 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 10.6.1 PROGRESSIVE COMPANIES
- 10.6.2 RESPONSIVE COMPANIES
- 10.6.3 DYNAMIC COMPANIES
- 10.6.4 STARTING BLOCKS
- 10.6.5 COMPETITIVE BENCHMARKING
- 10.6.5.1 Detailed list of key startups/SMEs
- 10.6.5.2 Competitive benchmarking of key startups/SMEs
- 10.7 BRAND/SOFTWARE COMPARATIVE ANALYSIS
- 10.8 COMPANY VALUATION AND FINANCIAL METRICS
- 10.9 COMPETITIVE SCENARIO
- 10.9.1 PRODUCT LAUNCHES & APPROVALS
- 10.9.2 DEALS
11 COMPANY PROFILES
- 11.1 KEY PLAYERS
- 11.1.1 OPTUM, INC.
- 11.1.1.1 Business overview
- 11.1.1.2 Products & services offered
- 11.1.1.3 Recent developments
- 11.1.1.3.1 Product launches & approvals
- 11.1.1.3.2 Deals
- 11.1.1.4 MnM view
- 11.1.1.4.1 Key strengths
- 11.1.1.4.2 Strategic choices
- 11.1.1.4.3 Weaknesses & competitive threats
- 11.1.2 COGNIZANT
- 11.1.2.1 Business overview
- 11.1.2.2 Products & services offered
- 11.1.2.3 Recent developments
- 11.1.2.3.1 Product launches & approvals
- 11.1.2.3.2 Deals
- 11.1.2.4 MnM view
- 11.1.2.4.1 Right to win
- 11.1.2.4.2 Strategic choices
- 11.1.2.4.3 Weaknesses & competitive threats
- 11.1.3 KONINKLIJKE PHILIPS N.V.
- 11.1.3.1 Business overview
- 11.1.3.2 Products offered
- 11.1.3.3 Recent developments
- 11.1.3.3.1 Product launches & approvals
- 11.1.3.3.2 Deals
- 11.1.3.3.3 Expansions
- 11.1.3.4 MnM view
- 11.1.3.4.1 Right to win
- 11.1.3.4.2 Strategic choices made
- 11.1.3.4.3 Weaknesses and competitive threats
- 11.1.4 DELL TECHNOLOGIES INC.
- 11.1.4.1 Business overview
- 11.1.4.2 Products offered
- 11.1.4.3 Recent developments
- 11.1.4.3.1 Product launches & approvals
- 11.1.4.3.2 Deals
- 11.1.4.4 MnM view
- 11.1.4.4.1 Right to win
- 11.1.4.4.2 Strategic choices
- 11.1.4.4.3 Weaknesses and competitive threats
- 11.1.5 GE HEALTHCARE
- 11.1.5.1 Business overview
- 11.1.5.2 Products offered
- 11.1.5.3 Recent developments
- 11.1.5.3.1 Product launches & approvals
- 11.1.5.3.2 Deals
- 11.1.5.4 MnM view
- 11.1.5.4.1 Right to win
- 11.1.5.4.2 Strategic choices
- 11.1.5.4.3 Weaknesses and competitive threats
- 11.1.6 ORACLE
- 11.1.6.1 Business overview
- 11.1.6.2 Products offered
- 11.1.6.3 Recent developments
- 11.1.6.3.1 Product launches & approvals
- 11.1.6.3.2 Deals
- 11.1.7 WIPRO
- 11.1.7.1 Business overview
- 11.1.7.2 Products offered
- 11.1.7.3 Recent developments
- 11.1.7.3.1 Product launches & approvals
- 11.1.7.3.2 Deals
- 11.1.8 ECLINICALWORKS
- 11.1.8.1 Business overview
- 11.1.8.2 Products offered
- 11.1.8.3 Recent developments
- 11.1.8.3.1 Product launches & approvals
- 11.1.8.3.2 Deals
- 11.1.9 SAS INSTITUTE INC.
- 11.1.9.1 Business overview
- 11.1.9.2 Products offered
- 11.1.9.3 Recent developments
- 11.1.9.3.1 Product launches & approvals
- 11.1.9.3.2 Deals
- 11.1.10 INOVALON
- 11.1.10.1 Business overview
- 11.1.10.2 Products offered
- 11.1.10.3 Recent developments
- 11.1.10.3.1 Product launches & approvals
- 11.1.10.3.2 Deals
- 11.1.11 INFOR (KOCH INDUSTRIES)
- 11.1.11.1 Business overview
- 11.1.11.2 Products offered
- 11.1.11.3 Recent developments
- 11.1.11.3.1 Product launches & approvals
- 11.1.11.3.2 Deals
- 11.1.12 CONIFER HEALTH SOLUTIONS, LLC.
- 11.1.12.1 Business overview
- 11.1.12.2 Products offered
- 11.1.12.3 Recent developments
- 11.1.13 NUANCE COMMUNICATIONS, INC.
- 11.1.13.1 Business overview
- 11.1.13.2 Products offered
- 11.1.13.3 Recent developments
- 11.1.13.3.1 Product launches & approvals
- 11.1.13.3.2 Deals
- 11.1.14 3M
- 11.1.14.1 Business overview
- 11.1.14.2 Products offered
- 11.1.14.3 Recent developments
- 11.1.14.3.1 Product launches & approvals
- 11.1.14.3.2 Deals
- 11.1.15 MERATIVE
- 11.1.15.1 Business overview
- 11.1.15.2 Products offered
- 11.1.15.3 Recent developments
- 11.1.15.3.1 Product launches & approvals
- 11.1.15.3.2 Deals
- 11.1.16 EPIC SYSTEMS CORPORATION
- 11.1.16.1 Business overview
- 11.1.16.2 Products offered
- 11.1.16.3 Recent developments
- 11.1.16.3.1 Product launches & approvals
- 11.1.16.3.2 Deals
- 11.1.17 INTERSYSTEMS CORPORATION
- 11.1.17.1 Business overview
- 11.1.17.2 Products offered
- 11.1.17.3 Recent developments
- 11.1.17.3.1 Product launches & approvals
- 11.1.17.3.2 Deals
- 11.1.18 VERADIGM LLC
- 11.1.18.1 Business overview
- 11.1.18.2 Products offered
- 11.1.18.3 Recent developments
- 11.1.19 SALESFORCE, INC.
- 11.1.19.1 Business overview
- 11.1.19.2 Products offered
- 11.1.19.3 Recent developments
- 11.1.20 CITIUSTECH INC
- 11.1.20.1 Business overview
- 11.1.20.2 Products offered
- 11.1.20.3 Recent developments
- 11.1.20.3.1 Product launches & approvals
- 11.1.20.3.2 Deals
- 11.2 OTHER PLAYERS
- 11.2.1 CONDUENT, INC.
- 11.2.2 CARESTREAM HEALTH.
- 11.2.3 PRACTICE FUSION, INC.
- 11.2.4 TATA CONSULTANCY SERVICES LIMITED
- 11.2.5 ELSEVIER
- 11.2.6 MEDEANALYTICS, INC.
- 11.2.7 MEDECISION
- 11.2.8 SURGICAL INFORMATION SYSTEMS
- 11.2.9 CHARTIS
- 11.2.10 CLEARWAVE CORPORATION
12 APPENDIX
- 12.1 DISCUSSION GUIDE
- 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 12.3 CUSTOMIZATION OPTIONS
- 12.4 RELATED REPORTS
- 12.5 AUTHOR DETAILS